What is the optimal timing for reading the Mantoux tuberculin skin test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Optimal Timing for Reading the Mantoux Tuberculin Skin Test

The Mantoux tuberculin skin test must be read between 48 and 72 hours after injection, when the delayed-type hypersensitivity reaction reaches maximum induration. 1, 2

Physiologic Rationale for the 48-72 Hour Window

The timing is based on the immunologic cascade of the delayed hypersensitivity response:

  • The tuberculin reaction begins 5-6 hours after injection with initial neutrophil infiltration 1
  • T-cell recruitment and lymphokine release occur progressively, with CD4 T-cells accumulating perivascularly by 48 hours 1
  • Maximum induration occurs at 48-72 hours due to peak inflammatory cell accumulation, local vasodilatation, edema, and fibrin deposition 1
  • The reaction then subsides over subsequent days 1

Critical Reading Guidelines

Measure only the transverse diameter of palpable induration (perpendicular to the long axis of the forearm), not erythema, and record in millimeters:

  • Reading should be performed in good light with the forearm slightly flexed at the elbow 1, 2
  • Use both inspection (from a side view against light) and palpation to determine induration boundaries 1, 2
  • The ball-point pen method reduces interobserver variability—gently push the pen tip at a 45° angle toward the injection site until it stops at the edge of induration 1, 2
  • Record "0 mm" rather than "negative" when no induration is present 1, 2
  • Trained healthcare professionals must perform the reading; patient self-reading is inaccurate and strongly discouraged 2, 3

Special Circumstances and Exceptions

Delayed Reactions in Specific Populations

  • In elderly patients or first-time test recipients, the reaction may not peak until after 72 hours 1
  • This delayed response does not alter test interpretation—the result remains valid 1

Reading After 72 Hours

  • Tests read after 72 hours tend to underestimate the true size of induration and should be avoided 1, 2
  • Research evidence shows that readings at 72 hours are significantly larger than at 48 hours (median 9.4 mm vs 4.95 mm), with 8.5% of subjects changing from negative to positive based on timing alone 4
  • However, one study found that subjects who fail to present at 48-72 hours may still have a reliable reading up to 144-168 hours (days 6-7), particularly useful in real-world settings where patients miss appointments 5

Distinguishing True from False Reactions

  • Immediate hypersensitivity reactions appear within hours but disappear by 24 hours and should not be confused with delayed hypersensitivity 1, 2
  • If a severe immediate reaction occurs, it may be prudent not to retest 1

Common Pitfalls to Avoid

  • Never measure or record erythema alone—only induration counts for interpretation 1, 2
  • Never accept patient self-reading—studies demonstrate poor accuracy 3
  • Never delay reading beyond 72 hours unless unavoidable—this underestimates induration size 1, 2, 4
  • Do not confuse immediate hypersensitivity (resolves by 24 hours) with the delayed reaction 1, 2

If Improper Injection Occurs

  • If no wheal forms during injection, immediately repeat the test at another site at least 2 inches away 2
  • Circle the second injection site to indicate which site should be read 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reading the tuberculin skin test. Who, when, and how?

Archives of internal medicine, 1988

Research

Comparing interferon- gamma release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.